Emma Betuel

The Latest from Emma Betuel

Limbix releases clinical trial data on a self-guided mental health app for teens

In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. SparkRx is a self-guided therapy program for teens run entirely on

NFX-backed Pepper Bio Emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re

SkyCell raises a $35 million series C round and enters COVID-19 vaccine distribution market

SkyCell, a Swiss company developing smart containers for transporting medicines and vaccines, is announcing a significant round of funding. On top of a $62 million round that closed last year, the com

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut

Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday. The company aims to raise about $125 million with the IPO

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approac

How four-person startup Luminopia is using TV to treat lazy eye 

If you’re diagnosed with lazy eye — otherwise known as amblyopia — as a child, there are only a few options at your disposal. You can wear an eye patch, you can take eye drops or you can

Activ Surgical raises $45 million Series B round to give surgeons eagle eyes

Activ Surgical, a Boston-based digital surgery company, announced a $45 million Series B round on Thursday. The round comes during a critical year for Activ Surgical. It’s in the process of developi

The Blue Box is betting on the future of at-home breast cancer tests

You can take a pregnancy test or colon cancer test from your bathroom, or, these days, a COVID-19 test from the comfort of your living room. You might one day be able to get a breast cancer screening

Alpha Medical closes $24M Series B round to expand women’s telehealth — without the video calls

Alpha Medical, a telemedicine company focused on women’s healthcare, closed a $24 million Series B round on Tuesday. It’s another company situated squarely in the crosshairs of a pandemic-fueled b

Ginkgo Bioworks, valued at $15B, begins trading today: Here’s how their business works

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Ginkgo’s market debut is one of the largest in biotech history. It

How Colossal sold investors on a quest to resurrect a woolly mammoth

There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to

DotCom Therapy raises $13M to provide therapy for kids, in and out of school

DotCom Therapy, a pediatric teletherapy company, just closed a $13 million Series A round. It’s far from the only teletherapy company looking to capitalize on a boom in venture capital investment in

Breakout ‘CRISPR platform’ company Mammoth Biosciences is officially a unicorn

The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says.  The billion-dollar valuation comes on the back of a $150 million Series D round led by Redmile Group,

Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products

Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment

Digital therapy program for fibromyalgia receives FDA breakthrough device designation

Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12-week smartphone-assisted fibromyalgia management program. This is the company’s f

GSK and R/GA Ventures are launching a health studio for startups

GSK Next, the innovation arm of GSK Consumer Healthcare, is launching a new mentorship and business development program. Called the Re/Wire Health Studio, the program will eventually select six startu

Aduhelm approval sparks HHS watchdog review of FDA’s accelerated approval pathway

The Department of Health and Human Services (HHS) Office of the Inspector General will review the FDA’s accelerated approval pathway, the office announced Wednesday. This sweeping review comes just

As the delta variant surges, a nonprofit app lets hospital patients call home for free on any device 

COVID Tech Connect, a nonprofit created during the first wave of the coronavirus pandemic in the United States, is launching a free app aimed at helping hospital patients call home. As the delta varia

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday.  According to S-1 filings, shares were estimated to price between $14 and $16 last

Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”

Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a prescription, a wearable sensor and an app. Today, a new FDA designation
Load More